| Tsz Y Lau, MD | |
|
16659 Southwest Freeway, Mob 1, Suite 440, Sugar Land, TX 77479-0001 | |
| (346) 874-2525 | |
| (346) 874-2526 |
| Full Name | Tsz Y Lau |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 18 Years |
| Location | 16659 Southwest Freeway, Sugar Land, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326237389 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | T0550 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Houston Methodist Sugarland Hospital | Sugar land, TX | Hospital |
| Houston Methodist West Hospital | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tmh Physician Associates Pllc | 4486711744 | 1557 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2018, the fixed dose coformulation of Tibotec's rilpivirine and Gilead's Truvada will achieve blockbuster sales of more than $2 billion in the HIV drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
The MEDICREA Group, listed on Alternext by NYSE - Euronext Paris, a company specialized in the development of innovative surgical technologies for the treatment of spinal pathologies, announces its audited 2011 annual results approved by the Board meeting of March 29th 2012, as well as its sales for the 1st quarter of 2012.
Thousands of deaths from tuberculosis, an infectious bacterial disease, could be prevented using a new hand-held device that is being developed to detect potentially fatal drug resistance in less than 15 minutes.
Scientists at the Buck Institute have shown that mice suffering from a depletion of the antioxidant glutathione in dopamine-producing neurons developed nerve damage and symptoms associated with Parkinson's disease (PD) in humans.
› Verified 8 days ago
| Entity Name | Tmh Physician Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275779225 PECOS PAC ID: 4486711744 Enrollment ID: O20090401000100 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2018, the fixed dose coformulation of Tibotec's rilpivirine and Gilead's Truvada will achieve blockbuster sales of more than $2 billion in the HIV drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
The MEDICREA Group, listed on Alternext by NYSE - Euronext Paris, a company specialized in the development of innovative surgical technologies for the treatment of spinal pathologies, announces its audited 2011 annual results approved by the Board meeting of March 29th 2012, as well as its sales for the 1st quarter of 2012.
Thousands of deaths from tuberculosis, an infectious bacterial disease, could be prevented using a new hand-held device that is being developed to detect potentially fatal drug resistance in less than 15 minutes.
Scientists at the Buck Institute have shown that mice suffering from a depletion of the antioxidant glutathione in dopamine-producing neurons developed nerve damage and symptoms associated with Parkinson's disease (PD) in humans.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tsz Y Lau, MD 16659 Southwest Freeway, Mob 1, Suite 440, Sugar Land, TX 77479-0001 Ph: (346) 874-2525 | Tsz Y Lau, MD 16659 Southwest Freeway, Mob 1, Suite 440, Sugar Land, TX 77479-0001 Ph: (346) 874-2525 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2018, the fixed dose coformulation of Tibotec's rilpivirine and Gilead's Truvada will achieve blockbuster sales of more than $2 billion in the HIV drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
The MEDICREA Group, listed on Alternext by NYSE - Euronext Paris, a company specialized in the development of innovative surgical technologies for the treatment of spinal pathologies, announces its audited 2011 annual results approved by the Board meeting of March 29th 2012, as well as its sales for the 1st quarter of 2012.
Thousands of deaths from tuberculosis, an infectious bacterial disease, could be prevented using a new hand-held device that is being developed to detect potentially fatal drug resistance in less than 15 minutes.
Scientists at the Buck Institute have shown that mice suffering from a depletion of the antioxidant glutathione in dopamine-producing neurons developed nerve damage and symptoms associated with Parkinson's disease (PD) in humans.
› Verified 8 days ago
John Jungsik Park, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 16605 Southwest Fwy, Suite 285, Sugar Land, TX 77479 Phone: 281-313-0031 | |
Dr. Rajesh Kumar Bindal, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 16605 Sw Frwy, Suite 285, Sugar Land, TX 77479 Phone: 281-313-0031 Fax: 281-313-0032 | |
Dr. Krishanthan Vigneswaran, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 17520 W Grand Pkwy S Ste 450, Sugar Land, TX 77479 Phone: 713-486-7800 Fax: 713-486-7830 | |
Dr. Christopher Ang Sy, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 16651 Southwest Freeway, Mob 1, Suite 440, Sugar Land, TX 77479 Phone: 346-874-2525 Fax: 346-874-2526 |